Liver fibrosis with methotrexate - an overestimated risk?

Raul J Andrade^{1

2}, Einar S Björnsson^{3

4}

Affiliations

¹ Unidad de Gestión Clínica de Enfermedades Digestivas, Instituto de Investigación Biomédica de Málaga-IBIMA-Plataforma BIONAND, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Malaga, Spain. andrade@uma.es.
² Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain. andrade@uma.es.
³ Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
⁴ Department of Gastroenterology, Landspitali University Hospital Reykjavík, Reykjavík, Iceland.

Comment

Raul J Andrade et al. Nat Rev Gastroenterol Hepatol. 2023 Jun.

. 2023 Jun;20(6):347-348.

doi: 10.1038/s41575-023-00782-3.

Raul J Andrade^{1

2}, Einar S Björnsson^{3

4}

¹ Unidad de Gestión Clínica de Enfermedades Digestivas, Instituto de Investigación Biomédica de Málaga-IBIMA-Plataforma BIONAND, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Malaga, Spain. andrade@uma.es.
² Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain. andrade@uma.es.
³ Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
⁴ Department of Gastroenterology, Landspitali University Hospital Reykjavík, Reykjavík, Iceland.

No abstract available

Comment on

Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
Atallah E, Grove JI, Crooks C, Burden-Teh E, Abhishek A, Moreea S, Jordan KM, Ala A, Hutchinson D, Aspinall RJ, Murphy R, Aithal GP. Atallah E, et al. J Hepatol. 2023 May;78(5):989-997. doi: 10.1016/j.jhep.2022.12.034. Epub 2023 Jan 23. J Hepatol. 2023. PMID: 36702175

1. Zachariae, H. Methotrexate side-effects. Br. J. Dermatol. 122 (Suppl. 36), 127–133 (1990). - DOI - PubMed
1. Whiting-O’Keefe, Q. E., Fye, K. H. & Sack, K. D. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am. J. Med. 90, 711–716 (1991). - DOI - PubMed
1. Arena, U. et al. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. Dig. Liver Dis. 44, 149–153 (2012). - DOI - PubMed
1. Atallah, E. et al. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. J. Hepatol. https://doi.org/10.1016/j.jhep.2022.12.034 (2023). - DOI - PubMed
1. Vali, Y. et al. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis. J. Hepatol. 73, 252–262 (2020). - DOI - PubMed